US Oncology operates a network of integrated community-based oncology practices that provides cancer care services in the United States. read more

EMPLOYEE PARTICIPANTS: 79

TOTAL RATINGS: 549

CEO: Bruno Strigini

Bruno Strigini US Oncology CEO Rating

US Oncology's CEO, Bruno Strigini, has 50 employee ratings and a score of 57/100, placing them in the Bottom 15% of similar size companies on Comparably with 10,000+ Employees and Bottom 20% of other companies in Houston. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that males at US Oncology rate Bruno Strigini higher than females, giving the CEO a score of 67/100.

Last updated months ago.

Where This Score Ranks US Oncology's CEO Rating

BOTTOM
15%
In the Bottom 15% of 1339 Similar Sized Companies on Comparably
BOTTOM
20%
In the Bottom 20% of 65 Nearby Companies in Houston
4th
4th place versus 3 competitors rated on Comparably

Aug

Nov

Dec

Jan

Sep

D57 / 100

Jan

US Oncology CEO Bruno Strigini Bio

Bruno Strigini serves as the CEO / President of US Oncology.

Who Ranks US Oncology's CEO Rating the Highest?

Department - Operations 70/100

Gender - Male 67/100

Tenure - 2 to 5 Years 63/100

Who Ranks US Oncology's CEO Rating the Lowest?

Experience - Over 10 Years 52/100

Gender - Female 59/100

Ethnicity - Caucasian 61/100

US Oncology CEO Bruno Strigini At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at US Oncology.

Based on 50 ratings, Bruno Strigini ranks right below Genzyme's CEO, David Meeker.

US Oncology's CEO is highly regarded by the Operations department, Male employees, and employees who have been at the company 2 to 5 Years. However, employees with Over 10 Years experience, Female employees, and Caucasian employees have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.